Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)โข Click on a phase to view related trials
A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2015-06-24
- Lead Sponsor
- AmpliMed Corporation
- Registration Number
- NCT00697060
- Locations
- ๐บ๐ธ
USC Norris Cotton Cancer Center, Los Angeles, California, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธMary Crowley Research Center, Dallas, Texas, United States
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
- Conditions
- Pancreatic Neoplasms
- Interventions
- First Posted Date
- 2008-03-17
- Last Posted Date
- 2019-03-20
- Lead Sponsor
- AmpliMed Corporation
- Target Recruit Count
- 142
- Registration Number
- NCT00637247
- Locations
- ๐บ๐ธ
Birmingham Hematology and Oncology- US Oncology, Birmingham, Alabama, United States
๐บ๐ธAZ Onc Associates D.B.A. Hematology Oncology- US Oncology, Tucson, Arizona, United States
๐บ๐ธArizona Clinical Research Center, Tucson, Arizona, United States
Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
- Conditions
- Pancreatic Adenocarcinoma
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2010-09-15
- Lead Sponsor
- AmpliMed Corporation
- Target Recruit Count
- 105
- Registration Number
- NCT00327327
- Locations
- ๐บ๐ธ
Arizona Clinical Research Center, Tucson, Arizona, United States
๐บ๐ธUS Oncology Orlando, Cancer Centers of FL, Ocoee, Florida, United States
๐บ๐ธUS Oncology Indiana, Indianapolis, Indiana, United States
Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2010-09-15
- Lead Sponsor
- AmpliMed Corporation
- Target Recruit Count
- 68
- Registration Number
- NCT00327600
- Locations
- ๐บ๐ธ
Investigational Site 009, Los Angeles, California, United States
๐บ๐ธInvestigational Site 002, Santa Monica, California, United States
๐บ๐ธUniversity of CO Anschutz Cancer Pavilion, Aurora, Colorado, United States
Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients
- Conditions
- Multiple Myeloma
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2009-08-11
- Lead Sponsor
- AmpliMed Corporation
- Registration Number
- NCT00327249
- Locations
- ๐บ๐ธ
Investigational Site 025, Little Rock, Arkansas, United States
๐บ๐ธInvestigational Site 008, Houston, Texas, United States
- Prev
- 1
- 2
- Next